ThePharmYard > Strategies for Overcoming the Internal Challenges between Rx and OTC

Click here to see all VirSci Corporation titles in ThePharmYard

Pay-as-you-go medical and pharmaceutical industry information

About Us | Contact Us | Terms

Managed by NetworkPharma

Sales+Marketing

Strategies for Overcoming the Internal Challenges between Rx and OTC

Written by Jack Pfister this expert paper was originally published in Pharma Marketing News, Vol 3 No 1.

Product Details - See below for further product information
Note the document you buy is licensed for your own use only.

File type and size: PDF 0.281 MB
Publication size: 5 pages
Publication date: January 2004
Published by: VirSci Corporation
ThePharmYard product code: vsc020

Our Price: £5.35
You are buying an e-document. This is a digital product and therefore UK VAT @ 17.50 % will be added at Checkout if your billing address is in the EU.

Related Products:

Evaluation of in-market communications of selected OTC products targeted to older consumers

Further Product Information

ABSTRACT

Why is the decision to switch from Rx to OTC usually considered a challenge? Is it because Rx and OTC marketing are seen as two separate sectors of a drug's product life cycle, with OTC always serving as the final stage? Or is it the stigma of lower profitability, deserved or not, that OTC-only marketing carries? These perceptions - or misconceptions - may sometimes cause a company's general management to be reluctant to concede to switching until the optimal timing for maximizing the contribution of a brand has passed.

In fact, OTC is a strategic option for extending a product's revenue stream and is not automatically the death knell to the prescription business. If Rx and OTC marketers construct a master life cycle strategy together, they can turn the paradigm of switching from a risk to an opportunity.

That was the message delivered by Bruce Lifka, Senior Director, Hair Growth and Rx/OTC Switches for Pfizer, at The Institute for International Research's RX to OTC Switch Marketers Forum held in Philadelphia in November, 2003.

The article:

discusses switching in context of targeting different patient types in which a category expansion strategy would not erode patient office visits,

provides several real-life cases where switching was an effective brand-building strategy, and

suggests a strategy for aligning corporate goals and incentives to facilitate the change from product management to molecule management

Strategic Medcomms Forum 2010:
Reshaping the healthcare conversation

30 September 2010

Oxford University Museum of Natural History, Oxford, UK

Learn more here

What we do

ThePharmYard sells information relevant to the medical and pharmaceutical industries, on behalf of independent publishers, in the form of e-documents. Buy online now and access the information immediately.

If you have any problems or questions or comments of any sort, then do please contact us directly.

All transactions conducted independently by WorldPay

basket

checkout

terms

Browse all publications in ThePharmYard from VirSci Corporation.

Selected Special Offers

1. Venlafaxine in Depression (in Primary Care)

2. Tiotropium in COPD (in Primary Care)

3. Pravastatin in Lipid Disorders (in Primary Care)

4. Escitalopram in Depression (in Primary Care)

5. Nicorandil in Angina (in Primary Care)

Our Best Sellers

1. An overview of CME/CPD credit systems around the world

2. Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications

3. Stepping up to Medical Sales Success - 2nd Edition

4. Quid Pro Quo Deals

5. Bipolar disorder - Disease overview

6. Bipolar disorder - Improving Practice (UK)

7. Olanzapine in bipolar disorder - Drug review

8. Developing Win-Win Key Opinion Leader Relationships

9. Levocetirizine in Allergic Rhinitis (in Primary Care)

10. Customer-Driven Positioning: The next generation approach to pharmaceutical product positioning

Latest Additions

1. Future of European Pharmaceutical Distribution

2. Global Dental Implants Market (2010 -2015)

3. Discretion is the better part of value: Five research-based rules for ensuring that strategy implementers implement

4. The competitive environment and hospital performance: An empirical investigation

5. Antecedents, environmental moderators and consequences of market orientation: A study of pharmaceutical firms in Ghana

Need help?

If you can't find what you are looking for, or have any problems or questions or comments at all, then please contact us directly.

If you are an Author or Publisher and have one or more publications you would like to make available to our specialist medical and pharmaceutical industry audience, then please contact us directly.

If you run your own web site and want to earn money from our affiliate scheme then please contact us directly.

Affiliates | About Us | Contact Us | Terms

ThePharmYard is an initiative for the international medical and pharmaceutical industries from NetworkPharma Ltd. Copyright 2010

Other services managed by NetworkPharma: [www.EuropeanCMEforum.eu] [www.KeywordPharma.com] [www.MedCommsForum.com] [www.MedCommsNetworking.co.uk] [www.NetworkPharma.tv] [www.ThePublicationPlan.com]

We accept the following credit and debit cards: amex visa visa_delta visa_electron mastercard switch jcb solo